Aperio Technologies, Inc. Introduces New Fluorescence Scanner for Whole Slide Imaging of Immunofluorescence and Analysis of Biomarker Expression

VISTA, Calif.--(BUSINESS WIRE)--Today at the 100th annual meeting of the American Association of Cancer Research (AACR) being held at the Colorado Convention Center in Denver, Aperio Technologies, Inc., (Aperio) a global leader in digital pathology for the healthcare and life sciences industry, unveiled its new digital slide scanner dedicated to fluorescence whole slide scanning. The ScanScope® FL, a 5-slide fluorescence scanning system, was designed to meet the growing demand for fluorescence whole slide scanning and quantitative analysis of tissues and TMAs with multiplexed biomarkers.